IRCT20200623047897N1
Completed
Phase 3
Evaluation of the efficacy and safety of oral N-acetylcysteine in treatment and recovery of patients with COVID-19 who are under treatment with routine protocols
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- covid-19.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •admitted patients with COVID\-19
- •moderate to severe, stable patients
Exclusion Criteria
- •unstable and intubated ICU patients
- •pregnancy, breastfeeding infancy
- •allergy and intolerance to NAC
- •unstable vital signs or need for intubation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaHealth Condition 1: L811- ChloasmaHealth Condition 2: O- Medical and SurgicalCTRI/2021/08/035350Department of Dermatology42
Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
Not yet recruiting
Phase 3
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childreCTRI/2024/02/063274IMS and SUM Hospital
Not yet recruiting
Not Applicable
To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.Health Condition 1: L609- Nail disorder, unspecifiedCTRI/2020/12/029904Dr Ruchir M Bhatt
Completed
Phase 3
Therapeutic effect of oral NAC on SinusitisIRCT138806112406N1Research managment center of Bushehr University of Medical Sciences45